Publications
Export 7 results:
Author Title [ Year
Filters: Keyword is Triple Negative Breast Neoplasms [Clear All Filters]
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nat Cancer. 2022 ;3(3):355-370.
. Microbial metabolite as icebreaker for immunotherapy. Cell Metab. 2022 ;34(4):506-507.
. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis. Nat Cancer. 2022 ;3(1):43-59.
. Tumor-derived Jagged1 promotes cancer progression through immune evasion. Cell Rep. 2022 ;38(10):110492.
. Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer. Med (N Y). 2021 ;2(6):736-754.
. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis. Cancer Res. 2020 ;80(18):3820-3829.
. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell. 2019 ;35(1):64-80.e7.
.